| Dr Benjamin W Szerlip, DO | |
|
70 S Cleveland Ave, Westerville, OH 43081-1397 | |
| (614) 890-6555 | |
| Not Available |
| Full Name | Dr Benjamin W Szerlip |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 15 Years |
| Location | 70 S Cleveland Ave, Westerville, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407153943 | NPI | - | NPPES |
| 348196202 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | Q0575 (Texas) | Secondary |
| 207X00000X | Orthopaedic Surgery | 58.003469 (Ohio) | Secondary |
| 207X00000X | Orthopaedic Surgery | 34.014743 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Halcyon Home Llc | Austin, TX | Home health agency |
| Cedar Park Regional Medical Center | Cedar park, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Timberland Medical Group | 7719875491 | 39 |
News Archive
A newly developed time-released muco-adhesive patch for treating oral health conditions, including the widespread condition of dry mouth (xerostomia), has been shown to be more effective than a leading oral rinse, according to a newly-published study. As increasing segments of the population consume more medications (one of the leading causes of dry mouth), the results of this study could potentially help provide relief for millions of Americans.
The Anglia Ruskin Medtech Campus Business Network Services have been developed in partnership with Chelmsford City Council, Harlow District Council and Southend-on-Sea Borough Council as part of plans to form the largest MedTech cluster in the UK over three development sites in Essex.
"After a weeklong overseas trip that pushed him to the fringes of Washington's health care debate, Mr. Obama moved aggressively to reclaim control," the New York Times reports.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
› Verified 6 days ago
| Entity Name | Timberland Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528061157 PECOS PAC ID: 7719875491 Enrollment ID: O20040514000302 |
News Archive
A newly developed time-released muco-adhesive patch for treating oral health conditions, including the widespread condition of dry mouth (xerostomia), has been shown to be more effective than a leading oral rinse, according to a newly-published study. As increasing segments of the population consume more medications (one of the leading causes of dry mouth), the results of this study could potentially help provide relief for millions of Americans.
The Anglia Ruskin Medtech Campus Business Network Services have been developed in partnership with Chelmsford City Council, Harlow District Council and Southend-on-Sea Borough Council as part of plans to form the largest MedTech cluster in the UK over three development sites in Essex.
"After a weeklong overseas trip that pushed him to the fringes of Washington's health care debate, Mr. Obama moved aggressively to reclaim control," the New York Times reports.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
› Verified 6 days ago
| Entity Name | Orthopaedic Associates Of Central Tx Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518061092 PECOS PAC ID: 3971583840 Enrollment ID: O20040721001334 |
News Archive
A newly developed time-released muco-adhesive patch for treating oral health conditions, including the widespread condition of dry mouth (xerostomia), has been shown to be more effective than a leading oral rinse, according to a newly-published study. As increasing segments of the population consume more medications (one of the leading causes of dry mouth), the results of this study could potentially help provide relief for millions of Americans.
The Anglia Ruskin Medtech Campus Business Network Services have been developed in partnership with Chelmsford City Council, Harlow District Council and Southend-on-Sea Borough Council as part of plans to form the largest MedTech cluster in the UK over three development sites in Essex.
"After a weeklong overseas trip that pushed him to the fringes of Washington's health care debate, Mr. Obama moved aggressively to reclaim control," the New York Times reports.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Benjamin W Szerlip, DO 70 S Cleveland Ave, Westerville, OH 43081-1397 Ph: (614) 890-6555 | Dr Benjamin W Szerlip, DO 70 S Cleveland Ave, Westerville, OH 43081-1397 Ph: (614) 890-6555 |
News Archive
A newly developed time-released muco-adhesive patch for treating oral health conditions, including the widespread condition of dry mouth (xerostomia), has been shown to be more effective than a leading oral rinse, according to a newly-published study. As increasing segments of the population consume more medications (one of the leading causes of dry mouth), the results of this study could potentially help provide relief for millions of Americans.
The Anglia Ruskin Medtech Campus Business Network Services have been developed in partnership with Chelmsford City Council, Harlow District Council and Southend-on-Sea Borough Council as part of plans to form the largest MedTech cluster in the UK over three development sites in Essex.
"After a weeklong overseas trip that pushed him to the fringes of Washington's health care debate, Mr. Obama moved aggressively to reclaim control," the New York Times reports.
Zalicus Inc., a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) filed by Mallinckrodt Inc., a subsidiary of Covidien plc, for the 32 mg dose strength of EXALGO (hydromorphone HCl) Extended-Release Tablets (CII), for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.
› Verified 6 days ago
Bruce Rodney Comisar Jr., MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 70 S Cleveland Ave, Westerville, OH 43081 Phone: 614-839-2128 Fax: 614-823-8881 | |
Mark Kolich, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 70 S Cleveland Ave, Westerville, OH 43081 Phone: 614-618-8897 | |
Dr. Charles D Kerr, D.O. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 70 S Cleveland Ave, Westerville, OH 43081 Phone: 614-890-6555 Fax: 614-823-8881 | |
David Leonard Louis, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 560 N Cleveland Ave, Westerville, OH 43082 Phone: 614-839-2300 Fax: 614-839-2301 | |
Merle L Kennedy, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 560 N Cleveland Ave, Westerville, OH 43082 Phone: 614-839-2300 Fax: 614-839-2301 | |
Dr. Mark E Gittins, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 70 S Cleveland Ave, Westerville, OH 43081 Phone: 614-890-6555 Fax: 614-823-8881 |